May 2024 has been an exciting month for women’s health, with several significant advancements specifically in HPV testing and cervical cancer prevention. These innovations are are set to advance cervical health, as they help make screening more accessible, less invasive, and ultimately more effective in saving lives.
These developments align with the World Health Organization’s (WHO) ambitious goal to eliminate cervical cancer as a public health issue by 2030. Achieving this goal involves widespread vaccination, regular screening, and timely treatment of precancerous conditions. Today our focus is on screening and more specifically screening for HPV.
HPV and Cervical Cancer: Understanding the Connection
Human Papillomavirus (HPV) is one of the most common sexually transmitted infections. Certain high-risk HPV types, such as HPV 16 and 18, are responsible for approximately 70% of cervical cancer cases. HPV can also cause throat and oral cancer, fertility problems, and other serious health issues. Early detection of HPV can lead to timely treatment and significantly reduce the risk of developing cervical cancer. Despite the availability of effective HPV vaccines, regular screening remains essential due to the vaccine’s coverage limitations and the need to monitor existing infections.
You’ve found some of our exclusive Inner Circle Content.
This article is only available for our Inner Circle Members. To read on:
